Bhaskar Chaudhuri Ph.D.
Net Worth
Last updated:
What is Bhaskar Chaudhuri Ph.D. net worth?
The estimated net worth of Dr. Bhaskar Chaudhuri Ph.D. is at least $14,196,973 as of 25 Jun 2021. He owns shares worth $13,105,506 as insider, has earned $889,787 from insider trading and has received compensation worth at least $201,680 in Arcutis Biotherapeutics, Inc..
What is the salary of Bhaskar Chaudhuri Ph.D.?
Dr. Bhaskar Chaudhuri Ph.D. salary is $50,420 per year as Co-Founder & Independent Director in Arcutis Biotherapeutics, Inc..
How old is Bhaskar Chaudhuri Ph.D.?
Dr. Bhaskar Chaudhuri Ph.D. is 70 years old, born in 1955.
What stocks does Bhaskar Chaudhuri Ph.D. currently own?
As insider, Dr. Bhaskar Chaudhuri Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | Co-Founder & Independent Director | 841,391 | $15.58 | $13,105,506 |
What does Arcutis Biotherapeutics, Inc. do?
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
Bhaskar Chaudhuri Ph.D. insider trading
Arcutis Biotherapeutics, Inc.
Dr. Bhaskar Chaudhuri Ph.D. has made 10 insider trades in 2021, according to the Form 4 filled with the SEC. Most recently he sold 6,755 units of ARQT stock worth $185,763 on 25 Jun 2021.
The largest trade he's ever made was exercising 10,000 units of ARQT stock on 22 Feb 2021. As of 25 Jun 2021 he still owns at least 841,391 units of ARQT stock.
Arcutis Biotherapeutics key executives
Arcutis Biotherapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Bhaskar Chaudhuri Ph.D. (70) Co-Founder & Independent Director
- Dr. Patrick E. Burnett M.D., Ph.D. (53) Senior Vice President & Chief Medical Officer
- Mr. Kenneth A. Lock (51) Chief Commercial Officer
- Mr. Todd Franklin Watanabe (57) Pres, Chief Executive Officer & Director